Gene Screening May Refine Prediction of Heart Attack Risk
Testing for 11 specific genetic variations in hundreds of people with no history of heart disease provided information that led to revision of their estimated heart attack risk.
Read MoreSearch Results for: diabetes testing
Ventana Medical Systems Inc
CLP spoke with Philippe Nore, international business leader—digital pathology with Ventana Medical Systems Inc, a member of the Roche Group, about its acquisition of digital pathology company BioImagene.
Read MoreData Suggest Veracyte’s Molecular Test Improves Accuracy of Thyroid Nodule Diagnosis
Veracyte Inc announced that initial data from its large-scale, prospective, multi-center clinical trial were presented today at the 14th International Thyroid Congress, held in Paris.
Read More
Incremental Improvements Deliver Big Value
Under pressure to deliver themselves, laboratories are demanding more from their instruments.
Read MoreDiazyme Cleared to Market SMART HbA1c Assay for Diabetes Monitoring
Diazyme Laboratories announced today that the FDA has granted Diazyme 510(k) clearance to market its SMART HbA1c Assay on its new SMART Point of Care System for diabetes monitoring.
Read More